Endometrial Carcinoma Presenting as Vasculitic Sensorimotor Polyneuropathy

Paraneoplastic syndromes (PNS) are a heterogeneous group of symptoms which are indirectly caused by primary or metastatic tumor. Paraneoplastic polyneuropathy (PNP) is mostly related to small cell lung cancer (5%), prostate, gastric, and breast cancer. Only sporadic cases have been reported to be as...

Full description

Saved in:
Bibliographic Details
Main Authors: Marketa Vasku (Author), Thomas Papathemelis (Author), Nicolai Maass (Author), Ivo Meinhold-Heerlein (Author), Dirk Bauerschlag (Author)
Format: Book
Published: Hindawi Limited, 2011-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_7a38f848a8f8413c9a8f50036e36612f
042 |a dc 
100 1 0 |a Marketa Vasku  |e author 
700 1 0 |a Thomas Papathemelis  |e author 
700 1 0 |a Nicolai Maass  |e author 
700 1 0 |a Ivo Meinhold-Heerlein  |e author 
700 1 0 |a Dirk Bauerschlag  |e author 
245 0 0 |a Endometrial Carcinoma Presenting as Vasculitic Sensorimotor Polyneuropathy 
260 |b Hindawi Limited,   |c 2011-01-01T00:00:00Z. 
500 |a 2090-6684 
500 |a 2090-6692 
500 |a 10.1155/2011/968756 
520 |a Paraneoplastic syndromes (PNS) are a heterogeneous group of symptoms which are indirectly caused by primary or metastatic tumor. Paraneoplastic polyneuropathy (PNP) is mostly related to small cell lung cancer (5%), prostate, gastric, and breast cancer. Only sporadic cases have been reported to be associated with endometrial cancer. We present a case of a premenopausal woman with severe vasculitic, asymmetric sensorimotor polyneuropathy that developed in conjunction with an endometrial carcinoma responding to surgical therapy of primary tumor combined to steroid therapy. Neurological symptoms such as asymmetrical sensorimotor deficits and painful paresthesias are suspicious when they occur in otherwise healthy women with no medical history. The phenomenon of a paraneoplastic syndrome can point to an underlying malignancy and can be used as marker of progression or regression of the tumor. Due to the rarity of PNP, there is no standard treatment. Recommended therapy is stage-adjusted treatment of the primary tumor. 
546 |a EN 
690 |a Gynecology and obstetrics 
690 |a RG1-991 
655 7 |a article  |2 local 
786 0 |n Case Reports in Obstetrics and Gynecology, Vol 2011 (2011) 
787 0 |n http://dx.doi.org/10.1155/2011/968756 
787 0 |n https://doaj.org/toc/2090-6684 
787 0 |n https://doaj.org/toc/2090-6692 
856 4 1 |u https://doaj.org/article/7a38f848a8f8413c9a8f50036e36612f  |z Connect to this object online.